BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements

BioRestorative Therapies, Inc.

CEO Lance Alstodt signed 3-year employment agreement with $600k annual salary, unchanged.
CFO Robert Kristal signed 3-year employment agreement with $350k annual salary, unchanged.
Shareholders approved increase in authorized common shares from 75M to 1.5B (20x).
Vote: 9,868,606 for, 2,389,059 against, 179,207 abstentions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BioRestorative Therapies, Inc. shareholders approved Approval of an amendment to the Company's Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 1,500,000,000 at the 2026-05-26 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2026-05-26

Exact text from the filing

1. Approval of an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 1,500,000,000: For 9,868,606 Against 2,389,059 Abstentions 179,207

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BioRestorative Therapies, Inc. filing history →

Source: SEC EDGAR

accession 0001021771-26-000084

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.